Rockville, MD (PRWEB) May 27, 2008
CME Outfitters, LLC, an independent accredited provider of multidisciplinary medical education programming and related healthcare communications services, announces an ongoing, interactive webcast titled "Using Evidence and Guidelines to Individualize Care for ACS: A Case-Based Presentation." Based on the live presentation that took place on March 29, 2008, at the Hilton Chicago, this webcast is available as an on-demand online archive and an additional live scheduled Q&A opportunity.
This activity will offer physician (CME), nursing (CNE), and pharmacy (CPE) credit, and provide an overview of current and emerging treatment strategies for patients with acute coronary syndrome.
There is no fee to participate or receive credit for this activity, however, advance registration is requested. You may register online at http://www.cmeoutfitters.com/PR293, or call 877.CME.PROS for more information.
This event is not part of the official ACC Annual Scientific Session and/or the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit as planned by their Program Committees.
Scheduled Date for Live Q&A:
Tuesday, June 17, 2008, 1:00 p.m. - 3:00 p.m. ET
Statement of Need:
Acute coronary syndrome (ACS) affects more than 1.5 million people in the United States each year, and is associated with an increased risk of cardiac death. Prevention of cardiac events in patients with ACS and those with prior myocardial infarction (MI) or stroke is crucial to improving outcomes and preventing death. Yet, almost half of all patients are under-recognized and not adequately managed. The American College of Cardiology/American Heart Association (ACC/AHA) have recently published new treatment guidelines for ACS, yet even when guidelines are incorporated in practice, some issues remain controversial. For instance, dosing and timing of the administration of antithrombotic therapies is not consistent and these factors can impact outcome. Also, clinicians need to know the importance of risk stratification in the management of ACS. In addition, short-term and long-term management strategies for ACS may differ, and there is not yet consensus in the field regarding best practices. Although current antithrombotic agents are effective, there is room for improvement in outcomes. Promising new agents, including PY212 inhibitors, thrombin receptor antagonists, and Factor Xa inhibitors may play a key role in improving patient care. Faculty in this interactive, case-based symposium will translate the latest evidence on treatment guidelines and emerging management strategies to improve practice, individualize treatments, and optimize outcomes of patients with ACS.
Christopher P. Cannon, MD
Senior Investigator, TIMI Study Group
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Robert A. Harrington, MD
Professor of Medicine, Division of Cardiology
Duke University Medical Center
Director, Duke Clinical Research Institute
Jeffrey L. Anderson, MD, FACC, FAHA, MACP
Associate Chief of Cardiology
Intermountain Medical Center
Co-Director of Cardiac Research
Professor of Internal Medicine
University of Utah
Salt Lake City, UT
At the end of this CE activity, participants should be able to:
- Describe the impact of treatment selection, dosing, and timing of antiplatelet therapies on overall outcomes of patients with acute coronary syndrome.
- Recognize the role of antithrombotic therapy in the prevention and management of acute coronary syndrome according to ACC/AHA guidelines.
- Evaluate emerging therapies in the management of patients with acute coronary syndrome.
Cardiologists, physician assistants, nurses, pharmacists, and other clinicians who treat patients with acute coronary syndrome.
CME Outfitters, LLC, gratefully acknowledges an independent educational grant from Schering-Plough Corporation in support of this CE activity.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.
CNE Credit (Nurses):
CME Outfitters, LLC, is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
It has been assigned code 6WASUP-PRV-0629. 2.0 contact hours will be awarded upon successful completion.
Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 2.0 contact hours (0.2 CEUs)
Universal Program Number: 376-000-08-005-L01-P (live presentation)
376-000-08-005-H01-P (recorded programs)
Participants in the archive and Q&A sessions held after the live symposium may receive credit and print a certificate online at http://www.cmeoutfitters.com/test.
About CME Outfitters:
CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www.cmeoutfitters.com or call 877.CME.PROS (877.263.7767).
For current information about this complimentary 2.0 hour CME activity, please visit http://www.cmeoutfitters.com/PR293.
Contact: Christopher Perez
CME Outfitters, LLC
# # #